EXACT Therapeutics AS (OSL:EXTX)
Norway · Delayed Price · Currency is NOK 0.7500
0.00 (0.00%)
At close: Aug 24, 2026
EXACT Therapeutics AS Market Cap
EXACT Therapeutics AS has a market cap or net worth of 47.45 million as of August 24, 2026. Its market cap has decreased by -70.70% in one year.
Market Cap
47.45M
Enterprise Value
23.54M
Revenue
59.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.75
ChartMarket Cap Chart
Since July 14, 2020, EXACT Therapeutics AS's market cap has decreased from 953.69M to 47.45M, a decrease of -95.02%. That is a compound annual growth rate of -38.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 47.45M | -45.65% |
| Dec 30, 2025 | 87.30M | -63.30% |
| Dec 30, 2024 | 237.87M | -38.21% |
| Dec 29, 2023 | 384.97M | 6.95% |
| Dec 30, 2022 | 359.97M | -31.02% |
| Dec 30, 2021 | 521.86M | -40.97% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 2.41B |
| Circio Holding ASA | 2.19B |
| Nykode Therapeutics AS | 1.47B |
| ArcticZymes Technologies ASA | 1.06B |
| Zelluna ASA | 655.93M |
| Lytix Biopharma ASA | 576.75M |
| Oncoinvent ASA | 372.60M |
| SoftOx Solutions AS | 226.36M |